Company intelligence / Profile preview

Genveon

Ownership: Private
Development stage: Commercial

Overview

Genveon (formerly Generica Pharmaceuticals) is a pharmaceutical company that markets a wide portfolio of original, equivalent, and OTC products for both acute and chronic markets. The company changed its name to Genveon in 2020 and has shown significant growth, with 73% growth in 2018 and 51% growth in 2019.

Therapeutic areas: Other
Modalities: Generic pharmaceuticalsOriginal pharmaceuticalsOTC products
Industry: Biotech

Beyond the preview

Go deeper on Genveon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genveon.

Explore the full profile